SOURCE: Insulet Corporation

Insulet Corporation

February 02, 2011 16:10 ET

Insulet Corporation to Report Fourth Quarter 2010 Financial Results on Tuesday, February 15, 2011

BEDFORD, MA--(Marketwire - February 2, 2011) - Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the fourth quarter of 2010 on Tuesday, February 15, 2011 after the close of the financial markets.

Insulet will also host a conference call at 5:00 p.m. Eastern Time on Tuesday, February 15, 2011 to discuss its fourth quarter 2010 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call, please dial 800-510-9691 for domestic callers and 617-614-3453 for international callers. The passcode is 86943006. A replay of the conference call will be available two hours after the start of the call through February 22, 2011 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 57382597. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://investors.insulet.com.

About Insulet Corporation
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA. For more information, please visit: www.myomnipod.com.

Contact Information

  • Contact:
    Stephanie Marks for Insulet Corporation
    Email Contact
    212-843-0211